DDMAC webinar provides guidance on marketing enforcement

09/6/2011

Warning Letters and Untitled Letters issued by the FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) during the past four months call out drug companies for alleged violations in a broad array of promotional vehicles, including materials on the Internet, according to an Enforcement Webinar held by DDMAC Aug. 25. "Marketers must pay attention to Internet promotions and detail aids that could violate FDA policies," said John Kamp, executive director of the Coalition for Healthcare Communication. Read more.

View Full Article in:

http://www.cohealthcom.org/2011/09/06/ddmac-calls-out-recent-marketing-violation...

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA